'Pharma bro' Martin Shkreli launched 'unmonitored drug trial' in Cyprus for Retrophin drug without FDA oversight ... - CNBC

CNBC

'Pharma bro' Martin Shkreli launched 'unmonitored drug trial' in Cyprus for Retrophin drug without FDA oversight ... CNBC Notorious "pharma bro" Martin Shkreli in 2014 launched an "unmonitored drug trial in Cyprus" — without FDA oversight — for a treatment being developed by his then-company Retrophin, federal prosecutors revealed Tuesday. Prosecutors said Shkreli had ... Martin Shkreli must forfeit $7.36 million, turn over stake in ultra-rare Wu-Tang Clan album: JudgeCNBC all 76 news articles »

Read more → http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNH5Amu18ERQ_-NZN5TM2v_tEARtMw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779822890078&ei=DKCfWrjeEonR3QHigIT4Cg&url=https://www.cnbc.com/2018/03/06/shkreli-launched-unmonitored-drug-trial-in-cyprus-for-retrophin-drug.html